cam a22 4 4500 528973045 CHVBK 20201001101731.0 180926s2018 enka b||| 001 0 eng| 2017302921 101721119 DNLM 978-1-78262-084-6 paperback 1-78262-084-2 paperback 978-1-78801-234-8 epub (IDSBB)006817185 (NEBIS)011067017 (OCoLC)1012811607 (OCoLC)989968279 (OCoLC)989968279 NLM ger NLM LTSCA OCLCF YDX GPRCL ITD OCLCO DLC BTCTA BDX EUM OCLCO SzZuIDS BS/BE B452 rda R856 .E44 2018 2018 A-936 W 82 610 15 610.28 23 a610.28 23 Engineering health how biotechnology changed medicine edited by Lara V. Marks London The Royal Society of Chemistry [2018] xii, 267 Seiten Illustrationen 23 cm Includes bibliographical references and subject index Biotechnology harnesses cellular and biochemical systems to advance knowledge of the molecular cause of disease and to provide new diagnostic tools and more precisely targeted drugs. Within a decade, global investment in medical biotechnology has increased more than ten-fold, resulting in therapies for previously untreatable conditions. But what exactly is biotechnology and what are its origins? What further benefits to human health could it offer in the future? In an accessible style, this book examines how biotechnology tools came to be discovered, how they are being used, and what the future of medicine could look like. Experts trace the development of biotechnologies such as DNA sequencing, gene therapy and monocolonal antibodies explaining how they are applied in medicine to combat disease. Find out about the science behind diagnostic technologies, such as cancer screening and pregnancy tests. Explore how genetic engineering has produced new vaccines. Applying new biotechnologies in medicine is not without great challenges. As medicines shift from small organic molecules to large, complex structures, such as therapeutic proteins, drugs become difficult to make, administer and regulate. This book will intrigue anyone who is interested in medicine and how we have been, and may continue to, engineer better health for ourselves Biomedizinische Technik (DE-588)4006882-1 gnd Biotechnologie (DE-588)4069491-4 gnd Medizin (DE-588)4038243-6 gnd Pharmazeutische Chemie (DE-588)4132158-3 gnd Biotechnology Biomedical Technology (DNLM)D020811 Biotechnology fast Biomedical engineering BIOCHEMISCHE BIOTECHNOLOGIE ger (ETHUDK)000044563 ethudk GENETISCHE THERAPIEN (MEDIZIN) ger (ETHUDK)000042933 ethudk IMMUNPHARMAKOLOGIE + IMMUNTHERAPIE + IMMUNPROPHYLAXE + IMMUNOLOGISCHE PRÄPARATE ger (ETHUDK)000026787 ethudk MEDIZINISCHE BIOCHEMIE + MEDIZINISCHE MOLEKULARBIOLOGIE ger (ETHUDK)000021734 ethudk MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN) ger (ETHUDK)000038652 ethudk SYNTHETISCHE BIOLOGIE ger (ETHUDK)000066277 ethudk ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE) ger (ETHUDK)000039312 ethudk u BIOCHEMISCHE BIOTECHNOLOGIE ger 573.6.002.577.1 nebis E1 u MEDIZINISCHE BIOCHEMIE + MEDIZINISCHE MOLEKULARBIOLOGIE ger 61.001'577 nebis E1 u MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN) ger 612.017.1,9.001.5.083.31.082.261 nebis E1 u ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE) ger 615.031 nebis E1 u GENETISCHE THERAPIEN (MEDIZIN) ger 616-085-056.7 nebis E1 u IMMUNPHARMAKOLOGIE + IMMUNTHERAPIE + IMMUNPROPHYLAXE + IMMUNOLOGISCHE PRÄPARATE ger 615.37 nebis E1 u SYNTHETISCHE BIOLOGIE ger 577*4 nebis E1 u BIOCHEMICAL ENGINEERING eng 573.6.002.577.1 nebis E1 u GÉNIE BIOCHIMIQUE fre 573.6.002.577.1 nebis E1 u BIOCHIMIE MÉDICALE + BIOLOGIE MOLÉCULAIRE MÉDICALE fre 61.001'577 nebis E1 u MEDICAL BIOCHEMISTRY + MEDICAL MOLECULAR BIOLOGY eng 61.001'577 nebis E1 u ANTICORPS MONOCLONAUX (TECHNIQUES IMMUNOLOGIQUES) fre 612.017.1,9.001.5.083.31.082.261 nebis E1 u MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES) eng 612.017.1,9.001.5.083.31.082.261 nebis E1 u MÉDICAMENTS CIBLÉS (PHARMACOLOGIE) fre 615.031 nebis E1 u TARGETED DRUGS (PHARMACOLOGY) eng 615.031 nebis E1 u THÉRAPIES GÉNIQUES (MÉDECINE) fre 616-085-056.7 nebis E1 u GENETIC THERAPIES (MEDICINE) eng 616-085-056.7 nebis E1 u IMMUNOPHARMACOLOGIE + IMMUNOTHÉRAPIE + MÉDICAMENTS IMMUN0LOGIQUES + MÉDICAMENTS IMMUNOPROPHYLACTIQUES fre 615.37 nebis E1 u IMMUNOTHERAPY + IMMUNOPHARMACOLOGY + IMMUNOLOGIC MEDICAMENTS + IMMUNOPROPHYLACTIC AGENTS eng 615.37 nebis E1 u SYNTHETIC BIOLOGY eng 577*4 nebis E1 u BIOLOGIE SYNTHÉTIQUE fre 577*4 nebis E1 Marks Lara 1963- (DE-588)131650432 Herausgeber edt BK020000 XK020000 XK020000 Stoppsignal FRED nebis DS 033 E01-20180129 130 E01-20180129 NEBIS E01 E01 MG T 80292 IDSBB B452 B452 452LB MED_W_82 10 NELB4521809 IDSBB 700 1- Marks Lara 1963- (DE-588)131650432 Herausgeber edt NEBIS 700 1- Marks Lara 1963- (DE-588)131650432 Herausgeber edt NEBIS EAD50 EBI01 E01 https://opac.nebis.ch/objects/pdf03/e01_978-1-78262-084-6_01.pdf Titelblatt und Inhaltsverzeichnis VIEW pdf